Skip to main content
. 2023 Jul 8;12(14):e027824. doi: 10.1161/JAHA.122.027824

Figure 4. Primary end point according to patient subgroups.

Figure 4

ACE indicates angiotensin‐converting enzyme; ARB, angiotensin receptor blockers; CCI, Charlson comorbidity index; NSTEMI, non–ST‐segment–elevation myocardial infarction; and SGLT2, sodium‐glucose cotransporter‐2.